Cell type–selective targeting by heterobifunctional protein binders via in-cell enrichment
Open Access
- 17 September 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 9929
Abstract
Non-catalytic heterobifunctional protein binders promise to expand the range of therapeutic options by establishing complexes between key target proteins and accessory presenter proteins equipped with additional properties. Here, we systematically investigate the rational design of such molecules, explore the biochemical basis of complex formation and determine how they achieve cellular efficacy using the endogenously expressed immunophilin FKBP12 as presenter protein and the transcriptional regulator BRD4 as target protein. We present classes of bifunctional molecules that enable selective, FKBP12-dependent killing of specific cell types at subnanomolar concentrations and allow to differentiate between closely related bromodomains of the BET family. We propose that the strongly potentiated efficacy of these bifunctional compounds is based on cellular enrichment through binding to the highly abundant presenter protein FKBP12, a mechanism we term “CellTrap”. Our findings substantiate the concept that highly expressed, non-essential proteins can be repurposed as selective recruiters to expand therapeutic windows of existing small-molecule inhibitors, opening new avenues for designing targeted drugs with improved cell-type specificity.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZU1109CB)
- Bundesministerium für Forschung, Technologie und Raumfahrt (03ZU1109CC)
This publication has 44 references indexed in Scilit:
- The Chemical Biology of Immunophilin LigandsCurrent Medicinal Chemistry, 2011
- Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight GainCell, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- MxCuBE: a synchrotron beamline control environment customized for macromolecular crystallography experimentsJournal of Synchrotron Radiation, 2010
- Fluorescent Probes to Characterise FK506‐Binding ProteinsChemBioChem, 2009
- FK506-binding protein (FKBP) partitions a modified HIV protease inhibitor into blood cells and prolongs its lifetime in vivoProceedings of the National Academy of Sciences, 2009
- Bifunctional molecules evade cytochrome P450metabolism by forming protective complexes with FK506-binding proteinMolecular BioSystems, 2008
- Sanglifehrin−Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray Crystal Structure, and Binding DataJournal of the American Chemical Society, 2003
- An exact mathematical expression for describing competitive binding of two different ligands to a protein moleculeFEBS Letters, 1995
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991